Close
Nordic 9Nordic 9

Max Altman (investor - Angel Investor)

United States
See something wrong or missing? Let us know
Offices:Austin

Max Altman is one of the brothers of Sam Altman and founder at Apollo Projects

Average round investment:30M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: United Kingdom Uncommon
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Max Altman

Name Criteria
United States Sam Altman
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rick Klausner
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom East Alpha
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Nutreco
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Agronomics Limited
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
France Five Seasons Ventures Sarl
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Point72 Ventures
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Singapore Clay Capital
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Netherlands Aqua-Spark
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top